Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group (Q33905155)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group (English)

1 reference

Europe PubMed Central

29 July 2017

6

object named as

Patrick Y Wen

1 reference

Europe PubMed Central

29 July 2017

author name string

Michael A Vogelbaum

1

1 reference

Europe PubMed Central

29 July 2017

Sarah Jost

2

1 reference

Europe PubMed Central

29 July 2017

Manish K Aghi

3

1 reference

Europe PubMed Central

29 July 2017

Amy B Heimberger

4

1 reference

Europe PubMed Central

29 July 2017

John H Sampson

5

1 reference

Europe PubMed Central

29 July 2017

David R Macdonald

7

1 reference

Europe PubMed Central

29 July 2017

Martin J Van den Bent

8

1 reference

Europe PubMed Central

29 July 2017

Susan M Chang

9

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 January 2012

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

70

1 reference

Europe PubMed Central

29 July 2017

1

1 reference

Europe PubMed Central

29 July 2017

234-43; discussion 243-4

1 reference

Europe PubMed Central

29 July 2017

Malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Response criteria for glioma

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Brain tumor imaging in clinical trials

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Steroid-induced CT changes in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Early postoperative magnetic resonance imaging following nonneoplastic cortical resection.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Clinical and radiographic features of peritumoral infarction following resection of glioblastoma.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Transient postictal MRI changes in patients with brain tumors may mimic disease progression.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Anatomic, physiologic and metabolic imaging in neuro-oncology

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Neuroimaging in patients with gliomas

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Postoperative contrast enhancement in patients with brain tumor.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Postoperative changes in the brain: MR imaging findings in patients without neoplasms.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Advanced MRI of adult brain tumors

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Clinical applications of PET in brain tumors

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Brain tumor volume measurement: comparison of manual and semiautomated methods.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Volumetric measurement of brain tumors from MR imaging.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E318223F5A7

21 January 2018

Identifiers

10.1227/NEU.0B013E318223F5A7

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33905155&oldid=1534902228"